A major US industrial is selling its Kautex and Textron Specialized Vehicles businesses for $1.2 billion (about $1.1 billion net cash after tax and costs), a big portfolio reshaping.
Pfizer gets exclusive rights outside Greater China to develop and make Starna's in vivo RNA medicines for autoimmune disease, extending big pharma's bet on RNA therapies.
A 1,635-bed ICE detention center changed hands to the federal government (DHS) for $453 million, alongside a planned $500 million accelerated share repurchase.
The world's largest industrial-automation firm is buying Austria-based AGILOX, a maker of AI-driven autonomous mobile robots (forklift-type), to push into warehouse and factory robotics.
Multi-year supply deal with Panasonic Energy of North America with potential for over $1 billion of offtake over time, to support domestic battery production.
Oversubscribed $87 million Series C (F-Prime, NEA, RA Capital, Sanofi Ventures; Eli Lilly participating) to take a Lyme disease vaccine candidate into the clinic.
Describes what it calls the largest ad-fraud operation ever disclosed by bid volume, running inside cheap consumer TV boxes and renting out victims' home internet connections without consent.
An 18-month plan for its first commercial-scale plant recovering gold from electronic waste, with capacity of about 40,000 gold-equivalent ounces a year.
Expands its Nov. 8 recall to two more products (a sausage, egg & cheese biscuit sandwich and a biscuit & sausage gravy meal) due to a possible health risk.